Chief Executive Officer
Shirin is the CEO and co-founder of Celluminova. She holds a Master of Science in biomedicine and a PhD in neuroscience with focus on stem cell biology. She did her postdoctoral studies at University of California San Francisco (UCSF) where she studied cancer stem cells in malignant brain tumors and has experience from working in the pharmaceutical industry.
Anne-Christine (Anki) Nilsson
Chief Operating Officer
Anki holds a Master of Science in Biology and a PhD in clinical chemistry with focus on carbohydrate interactions. She did her postdoctoral studies at Karolinska Institutet, Huddinge, in a collaboration with Recopharma AB, a biotech company. Anki has experience from pre-clinical research and in vitro diagnostics in several Biotech- and MedTech-companies at management level.
Chief Technology Officer
Marcus holds a Master of Science in chemistry and a PhD in organic chemistry, with focus on medicinal chemistry. He has over 10 years of experience within the development of luminescent ligands for detection and characterization of disease associated cell types and protein aggregates.
Product and Market developer
Cassandra holds a Master of Science in Chemical Biology and Engineering from Linköping University.